Emmett V. Schmidt
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0003-4687-9367Also affiliated with Massachusetts General Hospital, National Human Genome Research Institute, Cancer Research Center, Center for Cancer Research
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study”.
Amishi Y. Shah, Drew Rasco, Arpit Rao, Matthew H. Taylor, Christopher Di Simone +23 more
Michael R. Harrison, Peter H. O’Donnell, Ajjai Alva, Noah M. Hahn, Leonard J. Appleman +17 more
Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich +15 more
Abigail L. Shearin, Mary Lynch, Catherine André, Emmett V. Schmidt, Matthew Breen +15 more
Chuanwei Yang, Cuiqi Li, Mary Lynch, Emmett V. Schmidt, Sally Trent